← All organizations
Highest phase reached
Phase 3
First clinical trial
May 1, 2004Last known activity
Sep 30, 2025
Timeline
2000s
- May 1, 2004
PENTA Foundation— Founded
Drugs by trial phase (39 distinct, 22 trials)
Phase 3 (32 own, 0 via acquisition)
Phase 2 (4 own, 0 via acquisition)
Phase 1 (3 own, 0 via acquisition)
Indications
Recent trials (22)
- NCT07041190Lead sponsorPhase 3Sep 30, 2025
- NCT06873633Lead sponsorPhase 2Jun 30, 2025
- NCT06844500CollaboratorPhase 3Jun 23, 2025
- NCT06844487CollaboratorPhase 3May 29, 2025
- NCT06139796Lead sponsorPhase 1/Phase 2Jun 30, 2024
- NCT05993767Lead sponsorPhase 2Jan 31, 2024
- NCT05154747CollaboratorPhase 3Aug 31, 2022
- NCT04648280Lead sponsorPhase 1/Phase 2Jun 30, 2021
- NCT04337450Lead sponsorPhase 2/Phase 3Apr 1, 2021
- NCT04301154CollaboratorPhase 1Jun 30, 2020
- NCT03915366CollaboratorPhase 2/Phase 3Jan 1, 2020
- NCT02790996Lead sponsorPhase 2Feb 27, 2017
- NCT02383108Lead sponsorPhase 2/Phase 3Jun 1, 2016
- NCT02259127Lead sponsorPhase 2/Phase 3May 1, 2016
- NCT01825031CollaboratorPhase 3Jun 1, 2013
Details
- Founded
- Padova, IT May 1, 2004
- Last known activity
- Sep 30, 2025